Ovid Therapeutics
OVID • NASDAQ
Ovid Therapeutics is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Margaret Alexander, with a market cap of $435.0M.
Market Cap$435.0M
Employees40.0
CEOMargaret Alexander
CountryUnited States of America
Healthcare
Biotechnology
Next EarningsMay 12, 2026 · in a monthQ1 2026
Financials
Ovid Therapeutics FAQ
Common questions about Ovid Therapeutics
Ovid Therapeutics is scheduled to report earnings for Q1 2026 on May 12, 2026. Analysts estimate revenue of $81.0K.
Ovid Therapeutics has approximately 40 employees.